Modified Platform Trial Assessing Multiple Umbilical Cord-based CAMPs and SOC v SOC Alone in the Treatment of Hard-to-Heal DFUs

The purpose of this study is to evaluate the efficacy of two dehydrated human umbilical cord-based medical devices, also defined as Cellular, Acellular, Matrix-like Products/skin substitutes, plus SOC versus SOC alone in achieving complete closure of hard-to-heal diabetic foot ulcers over 12 weeks using a modified platform trial design.

NCT Number	NCT07449975
Lead Sponsor	StimLabs
Conditions	Diabetic Foot Ulcer (DFU), Ulcer Foot, Diabetic Foot, Foot Ulcer
Enrollment	272 participants
Start Date	2026-07
Primary Completion	2029-07 (estimated)
Study Completion	2029-09 (estimated)
Updated on ClinicalTrials.gov	2026-03-04